BioInvent International AB Alternatives & Competitors

12 companies similar to BioInvent International AB — BioInvent is translating cancer antibody biology into innovative immuno-oncology...

Trillium Therapeutics Inc.

Clinical stage immuno-oncology company developing innovative therapies for the treatment o...

14 Post-IPO Equity $281.98M

Cambridge, United States

Biopharma Biotechnology +1

Compare

Sensei Bio

We follow the immune system’s teachings to discover new treatments that inspire the body t...

32 Series B $58.50M

Rockville, United States

Biotechnology Health Care +2

Compare

Oxford BioTherapeutics

Redefining the cancer-immune synapse for novel immune checkpoint mechanisms

66 $28.09M

Oxford, United Kingdom

Biotechnology Health Care +1

ADC Therapeutics

Innovating Science. Inspiring Hope.

252 $1.27B

Lausanne, Switzerland

Biopharma Biotechnology +2

Track all BioInvent International AB competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Biotheus Inc.

To Inspire Each Other and Create Effective Medicines for Humankind

24 Acquired $919.50M

Zhuhai, China

Biotechnology Health Care

Prescient Therapeutics

A clinical stage oncology company developing personalised medicine approaches to cancer; c...

14 Post-IPO Equity $3.00M

Australia

Biopharma Biotechnology +3

DEM Biopharma, Inc.

Novel Target for Solid Tumors

20 $70.00M

Cambridge, United States

Biotechnology Life Sciences +1

Lisata Therapeutics, Inc.

Targeted Therapy Delivered

39 Acquired $4.44M

United States

Biotechnology Health and Wellness +1

Merus N.V.

Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community...

185 Post-IPO Equity $1.04B

Utrecht, The Netherlands

Biotechnology Health Care +1

Surface Oncology Inc.

#lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2...

14 Post-IPO Equity $88.90M

Cambridge, United States

Biotechnology Health Care +1

Bolt Biotherapeutics, Inc.

Plans to develop a novel format for T-cell mediated anti-tumour therapy

47 IPO $413.50M

Redwood City, United Stat...

Biotechnology Pharmaceutical

MediMabBio

A biotechnology company that focuses on developing new therapeutic drugs targeting Oncolog...

15 Non Equity Assistance

Korea South

Biotechnology Health Care +1

About BioInvent International AB

BioInvent International AB, a clinical-stage biotech firm founded in 1983 and headquartered in Sweden, is pioneering the landscape of immuno-oncology therapies by translating cancer antibody biology into innovative treatments. Leveraging its unique F.I.R.S.T™ technology platform, the company is at the forefront of disc...

Services

Antibody Discovery and Development, Clinical Programs in Immuno-oncology, Contract Manufacturing for Clinical Trials, Collaboration with Pharmaceutical Companies

Target Customers

Cancer Patients, Biotech and Pharmaceutical Companies, Medical Professionals, Clinical Researchers

Taxonomy

Immuno-Oncology, Antibody Drug Development, Hematological Cancer Therapy, Solid Tumor Therapy, F.I.R.S.T™ Technology Platform, N-CoDeR™ Antibody Library, Clinical-Stage Biotech, Research Collaborations, License Agreements, Antibody Manufacturing, Process Development, Antibody Drug Discovery, Co-Development Agreements, Proprietary Antibody Selection

Business Model

B2B, White Label, Platform

Revenue Model

Licensing, Service Fee, Project Based

Frequently Asked Questions

Companies similar to BioInvent International AB include Trillium Therapeutics Inc., Sensei Bio, Oxford BioTherapeutics, ADC Therapeutics, Biotheus Inc.. They work in Biotechnology and Health Care and share BioInvent International AB's focus on immuno-oncology and clinical-stage biotech.

Bounce Watch lists 12 companies that share BioInvent International AB's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches BioInvent International AB and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

BioInvent International AB Profile Trillium Therapeutics Inc. Alternatives Sensei Bio Alternatives Oxford BioTherapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at BioInvent International AB on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.